Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Helix BioPharma (TSE:HBP)
TSX:HBP
Helix BioPharma (HBP) Stock Price & Analysis
19 Followers
HBP Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.15 - C$0.30
Previous CloseC$0.22
Volume10.00
Average Volume (3M)6.67K
Market Cap
C$43.00M
Enterprise ValueC$40.18M
Total Cash (Recent Filing)C$2.82M
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)-6.6
Beta0.34
Next Earnings
Jun 13, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding200,018,859
10 Day Avg. Volume7,777
30 Day Avg. Volume6,668
Standard Deviation0.27
R-Squared0.00715
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
HBP FAQ
What was Helix BioPharma’s price range in the past 12 months?
Helix BioPharma lowest stock price was C$0.15 and its highest was C$0.30 in the past 12 months.
What is Helix BioPharma’s market cap?
Currently, no data Available
When is Helix BioPharma’s upcoming earnings report date?
Helix BioPharma’s upcoming earnings report date is Jun 13, 2023 which is in 13 days.
How were Helix BioPharma’s earnings last quarter?
Helix BioPharma released its earnings results on Mar 15, 2023. The company reported -C$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.006.
Is Helix BioPharma overvalued?
According to Wall Street analysts Helix BioPharma’s price is currently Overvalued.
Does Helix BioPharma pay dividends?
Helix BioPharma does not currently pay dividends.
What is Helix BioPharma’s EPS estimate?
Helix BioPharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Helix BioPharma have?
Helix BioPharma has 200,018,860 shares outstanding.
What happened to Helix BioPharma’s price movement after its last earnings report?
Helix BioPharma reported an EPS of -C$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Helix BioPharma?
Currently, no hedge funds are holding shares in TSE:HBP
---
Helix BioPharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.89%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
238.67%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Helix BioPharma
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.
---
Eupraxia Pharmaceuticals
―
ProMIS Neurosciences
―
Microbix Biosystms
―
Covalon Technologies
―
Resverlogix
―
---